izvor podataka: crosbi
!
Immunotherapy Response Assessment with F-18 FDG PET/CT in Metastatic Melanoma: First Results (CROSBI ID 713032)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Gordana Horvatic Herceg, Luka Simetić, Davorin Herceg, Martina Ciglar-Hlasc, Mario Lusic
Immunotherapy Response Assessment with F-18 FDG PET/CT in Metastatic Melanoma: First Results // The European Association of Nuclear Medicine (EANM). 2018
Podaci o odgovornosti
Gordana Horvatic Herceg, Luka Simetić, Davorin Herceg, Martina Ciglar-Hlasc, Mario Lusic
engleski
Immunotherapy Response Assessment with F-18 FDG PET/CT in Metastatic Melanoma: First Results
To explore the utility of the 18FDG-PET/CT for treatment monitoring in patients with metastatic melanoma receiving pembrolizumab.
18FDG-PET/CT, melanoma, immunotherapy, pembrolizumab
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
2018.
objavljeno
Podaci o matičnoj publikaciji
The European Association of Nuclear Medicine (EANM)
Podaci o skupu
Annual Congress of the European Association of Nuclear Medicine (EANM)
poster
13.10.2018-17.10.2018
Düsseldorf, Njemačka
